Inhibition Profiles of Some Symmetric Sulfamides Derived from Phenethylamines on Human Carbonic Anhydrase I, and II Isoenzymes.


Journal

Chemistry & biodiversity
ISSN: 1612-1880
Titre abrégé: Chem Biodivers
Pays: Switzerland
ID NLM: 101197449

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 30 05 2021
accepted: 12 08 2021
pubmed: 14 8 2021
medline: 15 12 2021
entrez: 13 8 2021
Statut: ppublish

Résumé

In this work, the inhibitory effect of some symmetric sulfamides derived from phenethylamines were determined against human carbonic anhydrase (hCA) I, and II isoenzymes, and compared with standard compound acetazolamide. IC

Identifiants

pubmed: 34387019
doi: 10.1002/cbdv.202100422
doi:

Substances chimiques

Carbonic Anhydrase Inhibitors 0
Phenethylamines 0
Sulfonamides 0
Carbonic Anhydrase I EC 4.2.1.-
Carbonic Anhydrase II EC 4.2.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2100422

Informations de copyright

© 2021 Wiley-VHCA AG, Zurich, Switzerland.

Références

G. Hanson, P. Venturelli, A. Fleckenstein, Drugs and society. 11. Edition. Burlington, MA: Jones & Bartlett Publishers, 2011.
S. L. Hill, S. H. Thomas, ‘Clinical toxicology of newer recreational drugs’, Clin. Toxicol. 2011, 49, 705-719.
E. M. Parker, L. X. Cubeddu, ‘Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding’, J. Pharmacol. Exp. Ther. 1988, 245, 199-210.
M. Nakamura, A. Ishii, D. Nakahara, ‘Characterization of β-phenylethylamine-induced monoamine release in rat nucleus accumbens: a microdialysis study’, Eur. J. Pharmacol. 1998, 349, 163-169.
I. Paterson, ‘The potentiation of cortical neuron responses to noradrenaline by 2-phenylethylamine is independent of endogenous noradrenaline’, Neurochem. Res. 1993, 18, 1329-1336.
G. B. Baker, R. Bornstein, A. Rouget, S. Ashton, J. Van Muyden, R. Coutts, ‘Phenylethylaminergic mechanisms in attention-deficit disorder’, Biol. Psychiatry 1991, 29, 15-22.
S. G. Potkin, F. Karoum, L.-W. Chuang, H. Cannon-Spoor, I. Phillips, R. J. Wyatt, ‘Phenylethylamine in paranoid chronic schizophrenia’, Science 1979, 206, 470-471.
D. E. Nichols, ‘Hallucinogens’, Pharmacol. Ther. 2004, 101, 131-181.
C. A. Lefebvre, E. Forcellini, S. Boutin, M.-F. Côté, C. René, P. Mathieu, P. Lagüe, J.-F. Paquin, ‘Synthesis of novel substituted pyrimidine derivatives bearing a sulfamide group and their in vitro cancer growth inhibition activity’, Bioorg. Med. Chem. Lett. 2017, 27, 299-302.
S. Göksu, A. Naderi, Y. Akbaba, P. Kalın, A. Akıncıoğlu, İ. Gülçin, S. Durdagi, R. E. Salmas, ‘Carbonic anhydrase inhibitory properties of novel benzylsulfamides using molecular modeling and experimental studies’, Bioorg. Chem. 2014, 56, 75-82.
C. Myung, L. Gyu, R. Seonggu, K. Hwan, J. Ho, S. Kyu, H. Young-Lan, Y. Hwan, Y. Young-Gwi, C. Bok, ‘Sulfamide derivatives and pharmaceutical composition for upregulation of lipid metabolism comprising same’, PCT Int. Appl. 2006, WO 2006006832.
C. Boss, W. Fischli, T. Weller, M. Clozel, M. Bolli, ‘Novel sulfamides’, PCT Int. Appl. 2006, WO 2006051502.
F. Jourdan, M. P. Leese, W. Dohle, E. Hamel, E. Ferrandis, S. P. Newman, A. Purohit, M. J. Reed, B. V. Potter, ‘Synthesis, antitubulin, and antiproliferative SAR of analogs of 2-methoxyestradiol-3, 17-O, O-bis-sulfamate’, J. Med. Chem. 2010, 53, 2942-2951.
C. Guo, L. Dong, S. Kephart, X. Hou, ‘An efficient synthesis of sulfamides’, Tetrahedron Lett. 2010, 51, 2909-2913.
G. Álvarez, B. Aguirre-López, J. Varela, M. Cabrera, A. Merlino, G. V. López, M. L. Lavaggi, W. Porcal, R. Di Maio, M. González, ‘Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity’, Eur. J. Med. Chem. 2010, 45, 5767-5772.
S. Kumar, V. Singh, M. Tiwari, ‘Quantitative structure-activity relationship studies of sulfamide derivatives as carbonic anhydrase inhibitor: as antiglaucoma agents’, Med. Chem. 2007, 3, 379-386.
A. Akıncıoğlu, H. Akıncıoğlu, I. Gülçin, S. Durdağı, C. T. Supuran, S. Göksu, ‘Discovery of potent carbonic anhydrase and acetylcholine esterase inhibitors: Novel sulfamoylcarbamates and sulfamides derived from acetophenones’, Bioorg. Med. Chem. 2015, 23, 3592-3602.
B. Ozgeriş, S. Göksu, L. Köse Polat, İ. Gülçin, R. E. Salmas, S. Durdagi, F. Tümer, C. T. Supuran, ‘Acetylcholinesterase and carbonic anhydrase inhibitory properties of novel urea and sulfamide derivatives incorporating dopaminergic 2-aminotetralin scaffolds’, Bioorg. Med. Chem. 2016, 24, 2318-2329.
A. Akıncıoğlu, Y. Akbaba, H. Göçer, S. Göksu, İ. Gülçin, C. T. Supuran, ‘Novel sulfamides as potential carbonic anhydrase isoenzymes inhibitors’, Bioorg. Med. Chem. 2013, 21, 1379-1385.
A. Akıncıoğlu, M. Topal, İ. Gülçin, S. Göksu, ‘Novel sulphamides and sulphonamides incorporating the tetralin scaffold as carbonic anhydrase and acetylcholine esterase inhibitors’, Arch. Pharm. 2014, 347, 68-76.
K. Aksu, M. Nar, M. Tanc, D. Vullo, İ. Gülçin, S. Göksu, F. Tümer, C. T. Supuran, ‘Synthesis and carbonic anhydrase inhibitory properties of sulfamides structurally related to dopamine’, Bioorg. Med. Chem. 2013, 21, 2925-2931.
Y. Akbaba, E. Bastem, F. Topal, İ. Gülçin, A. Maraş, S. Göksu, ‘Synthesis and carbonic anhydrase inhibitory effects of novel sulfamides derived from 1-aminoindanes and anilines’, Arch. Pharm. 2014, 347, 950-957.
S. B. Ozturk Sarıkaya, F. Topal, M. Şentürk, I. Gülçin, C. Supuran, ‘in vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds’, Bioorg. Med. Chem. Lett. 2011, 21, 4259-4262.
A. Günsel, P. Taslimi, G. Y. Atmaca, A. T. Bilgiçli, H. Pişkin, Y. Ceylan, A. Erdoğmuş, M. N. Yarasir, İ. Gülçin, ‘Novel potential metabolic enzymes inhibitor, photosensitizer and antibacterial agents based on water-soluble phthalocyanine bearing imidazole derivative’, J. Mol. Struct. 2021, 1237, 130402.
I. Gulcin, S. Beydemir, ‘Phenolic compounds as antioxidants: carbonic anhydrase isoenzymes inhibitors’, Mini-Rev. Med. Chem. 2013,13, 408-430.
A. Kazancı, Y. Gök, R. Kaya, A. Aktaş, P. Taslimi, İ. Gülçin, ‘Synthesis, characterization and bioactivities of dative donor ligand N-heterocyclic carbene (NHC) precursors and their Ag (I) NHC coordination compounds’, Polyhedron 2021, 193, 114866.
S. Burmaoglu, A. O. Yilmaz, M. F. Polat, R. Kaya, İ. Gulcin, O. Algul, ‘Synthesis of novel tris-chalcones and determination of their inhibition profiles against some metabolic enzymes’, Arch. Physiol. Biochem. 2021, 127, 153-161.
K. Pedrood, M. Sherafati, M. Mohammadi-Khanaposhtani, M. S. Asgari, S. Hosseini, H. Rastegar, B. Larijani, M. Mahdavi, P. Taslimi, Y. Erden, ‘Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives’, Int. J. Biol. Macromol. 2021, 170, 1-12.
S. Daşgın, Y. Gök, D. B. Celepci, P. Taslimi, M. İzmirli, A. Aktaş, İ. Gülçin, ‘Synthesis, characterization, crystal structure and bioactivity properties of the benzimidazole-functionalized PEPPSI type of Pd (II) NHC complexes’, J. Mol. Struct. 2021, 1228, 129442.
S. Hashmi, S. Khan, Z. Shafiq, P. Taslimi, M. Ishaq, N. Sadeghian, H. S. Karaman, N. Akhtar, M. Islam, A. Asari, ‘Probing 4-(diethylamino)-salicylaldehyde-based thiosemicarbazones as multi-target directed ligands against cholinesterases, carbonic anhydrases and α-glycosidase enzymes’, Bioorg. Chem. 2021, 107, 104554.
Ş. Beydemir, İ. Gülçin, ‘Effects of melatonin on carbonic anhydrase from human erythrocytes in vitro and from rat erythrocytes in vivo’, J. Enzyme Inhib. Med. Chem. 2004, 19, 193-197.
İ. Gülçin, B. Trofimov, R. Kaya, P. Taslimi, L. Sobenina, E. Schmidt, O. Petrova, S. Malysheva, N. Gusarova, V. Farzaliyev, ‘Synthesis of nitrogen, phosphorus, selenium and sulfur-containing heterocyclic compounds-Determination of their carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibition properties’, Bioorg. Chem. 2020, 103, 104171.
H. G. Bilgicli, D. Ergon, P. Taslimi, B. Tüzün, İ. A. Kuru, M. Zengin, İ. Gülçin, ‘Novel propanolamine derivatives attached to 2-metoxifenol moiety: Synthesis, characterization, biological properties, and molecular docking studies’, Bioorg. Chem. 2020, 101, 103969.
N. Lolak, S. Akocak, C. Türkeş, P. Taslimi, M. Işık, Ş. Beydemir, İ. Gülçin, M. Durgun, ‘Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1, 3, 5-triazine structural motifs’, Bioorg. Chem. 2020, 100, 103897.
T. Artunc, A. Menzek, P. Taslimi, I. Gulcin, C. Kazaz, E. Sahin, ‘Synthesis and antioxidant activities of phenol derivatives from 1,6-bis(dimethoxyphenyl)hexane-1,6-dione’, Bioorg. Chem. 2020, 100, 103884.
C. Caglayan, P. Taslimi, C. Türk, F.M. Kandemir, Y. Demir, I. Gulcin, ‘Purification and characterization of the carbonic anhydrase enzyme from horse mackerel (Trachurus trachurus) muscle and the impact of some metal ions and pesticides on enzyme activity’, Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2019, 226, 108605.
B. Arabaci, I. Gulcin, S. Alwasel, ‘Capsaicin: a potent inhibitor of carbonic anhydrase isoenzymes’, Molecules 2014, 19, 10103-10114.
T. A. Coban, Ş. Beydemir, İ. Gülçin, D. Ekinci, ‘Morphine inhibits erythrocyte carbonic anhydrase in vitro and in vivo’, Biol. Pharm. Bull. 2007, 30, 2257-2261.
M. Topal, İ. Gülçin, ‘Rosmarinic acid: a potent carbonic anhydrase isoenzymes inhibitor’, Turk. J. Chem. 2014, 38, 894-902.
H. Gocer, F. Topal, M. Topal, M. Küçük, D. Teke, İ. Gülçin, S. H. Alwasel, C. T. Supuran, ‘Acetylcholinesterase and carbonic anhydrase isoenzymes I and II inhibition profiles of taxifolin’, J. Enzyme Inhib. Med. Chem. 2016, 31, 441-447.
M. Boztas, Y. Cetinkaya, M. Topal, I. Gulcin, A. Menzek, E. Sahin, M. Tanc, C. T. Supuran, ‘Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties’, J. Med. Chem. 2015, 58, 640-650.
M. Boztas, P. Taslimi, M. A. Yavari, I. Gulcin, E. Sahin, A. Menzek, ‘Synthesis and biological evaluation of bromophenol derivatives with cyclopropyl moiety: Ring opening of cyclopropane with monoester’, Bioorg. Chem. 2019, 89, 103017.
A. Yıldırım, U. Atmaca, A. Keskin, M. Topal, M. Celik, İ. Gülçin, C. T. Supuran, ‘N-Acylsulfonamides strongly inhibit human carbonic anhydrase isoenzymes I and II’, Bioorg. Med. Chem. 2015, 23, 2598-2605.
A. Atasever, H. Ozdemir, I. Gulcin, O. I. Kufrevioglu, ‘One-step purification of lactoperoxidase from bovine milk by affinity chromatography’, Food Chem. 2013, 136, 864-870.
M. Güney, A. Coşkun, F. Topal, A. Daştan, İ. Gülçin, C. T. Supuran, ‘Oxidation of cyanobenzocycloheptatrienes: synthesis, photooxygenation reaction and carbonic anhydrase isoenzymes inhibition properties of some new benzotropone derivatives’, Bioorg. Med. Chem. 2014, 22, 3537-3543.
A. Scozzafava, M. Passaponti, C. T. Supuran, İ. Gülçin, ‘Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII)’, J. Enzyme Inhib. Med. Chem. 2015, 30, 586-591.
A. Scozzafava, P. Kalın, C. T. Supuran, İ. Gülçin, S. H. Alwasel, ‘The impact of hydroquinone on acetylcholine esterase and certain human carbonic anhydrase isoenzymes (hCA I, II, IX, and XII)’, J. Enzyme Inhib. Med. Chem. 2015, 30, 941-946.
M. Kucuk, İ. Gulcin, ‘Purification and characterization of the carbonic anhydrase enzyme from Black Sea trout (Salmo trutta Labrax Coruhensis) kidney and inhibition effects of some metal ions on enzyme activity’, Environ. Toxicol. Pharmacol. 2016, 44, 134-139.
U. M. Kocyigit, Y. Budak, M. B. Gürdere, Ş. Tekin, T. K. Köprülü, F. Ertürk, K. Özcan, İ. Gülçin, M. Ceylan, ‘Synthesis, characterization, anticancer, antimicrobial and carbonic anhydrase inhibition profiles of novel (3aR, 4S, 7R, 7aS)-2-(4-((E)-3-(3-aryl) acryloyl) phenyl)-3a, 4, 7, 7a-tetrahydro-1H-4, 7-methanoisoindole-1, 3 (2H)-dione derivatives’, Bioorg. Chem. 2017, 70, 118-125.
Ç. Bayrak, P. Taslimi, İ. Gülçin, A. Menzek, ‘The first synthesis of 4-phenylbutenone derivative bromophenols including natural products and their inhibition profiles for carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase enzymes’, Bioorg. Chem. 2017, 72, 359-366.
O. Hisar, Ş. Beydemir, İ. Gülçin, Ö. İ. Küfrevioğlu, C. T. Supuran, ‘Effect of low molecular weight plasma inhibitors of rainbow trout (Oncorhyncytes mykiss) on human erythrocytes carbonic anhydrase-II isozyme activity in vitro and rat erythrocytes in vivo’, J. Enzyme Inhib. Med. Chem. 2005, 20, 35-39.
S. Daryadel, U. Atmaca, P. Taslimi, İ. Gulçin, M. Çelik, ‘Novel sulfamate derivatives of menthol: Synthesis, characterization and cholinesterases and carbonic anhydrase enzymes inhibition properties’, Arch. Pharm. 2018, 351, e1800209.
U. Atmaca, C. Alp, H. Akincioglu, H. S. Karaman, İ. Gülçin, M. Çelik, ‘Novel Hypervalent Iodine Catalyzed Synthesis of α-Sulfonoxy Ketones: Biological Activity and Molecular Docking Studies’, J. Mol. Struct. 2021, 130492.
İ. Gülçin, A. Scozzafava, C. T. Supuran, Z. Koksal, F. Turkan, S. Çetinkaya, Z. Bingöl, Z. Huyut, S. H. Alwasel, ‘Rosmarinic acid inhibits some metabolic enzymes including glutathione S-transferase, lactoperoxidase, acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase isoenzymes’, J. Enzyme Inhib. Med. Chem. 2016, 31, 1698-1702.
D. Ozmen Ozgun, C. Yamali, H. İ. Gül, P. Taslimi, İ. Gülçin, T. Yanik, C. T. Supuran, ‘Inhibitory effects of isatin mannich bases on carbonic anhydrases, acetylcholinesterase and butyrylcholinesterase’, J. Enzyme Inhib. Med. Chem. 2016, 31, 1498-1501.
H. I. Gul, C. Yamali, F. Yesilyurt, H. Sakagami, K. Kucukoglu, I. Gulcin, M. Gul, C. T. Supuran, ‘Microwave-assisted synthesis and bioevaluation of new sulfonamides’, J. Enzyme Inhib. Med. Chem. 2017, 32, 369-374.
T. A. Coban, Ş. Beydemir, İ. Gücin, D. Ekinci, A. Innocenti, D. Vullo, C. T. Supuran, ‘Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I-XIV’, Bioorg. Med. Chem. 2009, 17, 5791-5795.
H. İ. Gül, M. Tuğrak, H. Sakagami, P. Taslimi, İ. Gülçin, C. T. Supuran, ‘Synthesis and bioactivity studies on new 4-(3-(4-substitutedphenyl)-3a,4-dihydro-3h-indeno[1,2-c]pyrazol-2-yl) benzenesulfonamides’, J. Enzyme Inhib. Med. Chem. 2016, 31, 1619-1624.
D. O. Ozgun, H. I. Gul, C. Yamali, H. Sakagami, I. Gulcin, M. Sukuroglu, C. T. Supuran, ‘Synthesis and bioactivities of pyrazoline benzensulfonamides as carbonic anhydrase and acetylcholinesterase inhibitors with low cytotoxicity’, Bioorg. Chem. 2019, 84, 511-517.
K. Aksu, F. Topal, I. Gulcin, F. Tümer, S. Göksu, ‘Acetylcholinesterase inhibitory and antioxidant activities of novel symmetric sulfamides derived from phenethylamines’, Arch. Pharm. 2015, 348, 446-455.
J. A. Verpoorte, S. Mehta, J. T. Edsall, ‘Esterase activities of human carbonic anhydrases B and C’, J. Biol. Chem. 1967, 242, 4221-4229.
B. Aydin, I. Gulcin, S. H. Alwasel, ‘Purification and characterization of polyphenol oxidase from Hemşin apple (Malus communis L.)’, Int. J. Food Prop. 2015, 18, 2735-2745.
M. Nar, Y. Çetinkaya, İ. Gülçin, A. Menzek, ‘(3,4-Dihydroxyphenyl)(2,3,4-trihydroxyphenyl)methanone and its derivatives as carbonic anhydrase isoenzymes inhibitors’, J. Enzyme Inhib. Med. Chem. 2013, 28, 402-406.
H. Lineweaver, D. Burk, ‘The determination of enzyme dissociation constants’, J. Am. Chem. Soc. 1934, 56, 658-666.
E. Köksal, İ. Gülçin, ‘Purification and characterization of peroxidase from cauliflower (Brassica oleracea L.) buds’, Protein Pept. Lett. 2008, 15, 320-326.
S. Akocak, P. Taslimi, N. Lolak, M. Işık, M. Durgun, Y. Budak, C. Türkeş, İ. Gülçin, Ş. Beydemir, ‘Synthesis, characterization, and inhibition study of novel substituted phenylureido sulfaguanidine derivatives as α-glycosidase and cholinesterase inhibitors’, Chem. Biodiversity 2021, 18, e2000958.
M. Isık, S. Beydemir, A. Yılmaz, M. E. Naldan, H. E. Aslan, İ. Gülçin, ‘Oxidative stress and mRNA expression of acetylcholinesterase in the leukocytes of ischemic patients’, Biomed. Pharmacother. 2017, 87, 561-567.
P. Taslimi, M. Işık, F. Türkan, M. Durgun, C. Türkeş, İ. Gülçin, Ş. Beydemir, ‘Benzenesulfonamide derivatives as potent acetylcholinesterase, α-glycosidase, and glutathione S-transferase inhibitors: biological evaluation and molecular docking studies’, J. Biomol. Struct. Dyn. 2021, 39, 5449-5460.
M. Işık, S. Akocak, N. Lolak, P. Taslimi, C. Türkeş, İ. Gülçin, M. Durgun, Ş. Beydemir, ‘Synthesis, characterization, biological evaluation, and in silico studies of novel 1, 3-diaryltriazene-substituted sulfathiazole derivatives’, Arch. Pharm. 2020, 353, 2000102.
B. Sever, C. Türkeş, M. D. Altıntop, Y. Demir, Ş. Beydemir, ‘Thiazolyl-pyrazoline derivatives: in vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors’, Int. J. Biol. Macromol. 2020, 163, 1970-1988.
F. Turkan, A. Cetin, P. Taslimi, M. Karaman, İ. Gülçin, ‘Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors’, Bioorg. Chem. 2019, 86, 420-427.
B. Yiğit, R. Kaya, P. Taslimi, Y. Işık, M. Karaman, M. Yiğit, İ. Özdemir, İ. Gulçin, ‘Imidazolinium chloride salts bearing wing tip groups: Synthesis, molecular docking and metabolic enzymes inhibition’, J. Mol. Struct. 2019, 1179, 709-718.
E. M. Duffy, W. L. Jorgensen, ‘Prediction of properties from simulations: free energies of solvation in hexadecane, octanol, and water’, J. Am. Chem. Soc. 2000,122, 2878-2888.
C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeney, ‘Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings’, Adv. Drug Delivery Rev. 1997, 23, 3-25.
M. T. Riaz, M. Z. Yaqup, Shafiq, Z. Ashraf, M. Khalid, P. Taslimi, R. Taş, B. Tuzun, İ. Gulçin, ‘Synthesis, biological activity and docking calculations of bis-naphthoquinone derivatives from lawsone’, Bioorg. Chem. 2021, 114, 105069.
S. Gündoğdu, C. Türkeş, M. Arslan, Y. Demir, Ş. Beydemir, ‘New isoindole-1, 3-dione substituted sulfonamides as potent inhibitors of carbonic anhydrase and acetylcholinesterase: Design, synthesis, and biological evaluation’, ChemistrySelect 2019, 4, 13347-13355.

Auteurs

Fevzi Topal (F)

Department of Chemical and Chemical Processing Technologies, Gümüşhane Vocational School, Gümüşhane University, Gümüşhane, 29100, Turkey.

Kadir Aksu (K)

Department of Chemistry, Faculty of Sciences and Arts, Ordu University, Ordu, 52200, Turkey.

Ilhami Gulcin (I)

Department of Chemistry, Faculty of Sciences, Atatürk University, Erzurum, 25240, Turkey.

Ferhan Tümer (F)

Department of Chemistry, Faculty of Sciences and Arts, Sütçü İmam University, Kahramanmaraş, 46100, Turkey.

Süleyman Goksu (S)

Department of Chemistry, Faculty of Sciences, Atatürk University, Erzurum, 25240, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH